v3.26.1
Description of Business - Schedule of Consolidated Financial Statements (Details)
 9 Months Ended
Apr. 30, 2026
Broad Atlantic Associates, LLC [Member]  
Schedule of Consolidated Financial Statements [Line Items]  
Country of Incorporation United States – Delaware
Percentage Owned 100.00%
IDT R.E. Holdings Ltd. [Member]  
Schedule of Consolidated Financial Statements [Line Items]  
Country of Incorporation Israel
Percentage Owned 100.00%
Rafael Holdings Realty, Inc. [Member]  
Schedule of Consolidated Financial Statements [Line Items]  
Country of Incorporation United States – Delaware
Percentage Owned 100.00%
Barer Institute, Inc. [Member]  
Schedule of Consolidated Financial Statements [Line Items]  
Country of Incorporation United States – Delaware
Percentage Owned 100.00% [1]
Hillview Avenue Realty, JV [Member]  
Schedule of Consolidated Financial Statements [Line Items]  
Country of Incorporation United States – Delaware
Percentage Owned 100.00%
Hillview Avenue Realty, LLC [Member]  
Schedule of Consolidated Financial Statements [Line Items]  
Country of Incorporation United States – Delaware
Percentage Owned 100.00%
Rafael Medical Devices, LLC [Member]  
Schedule of Consolidated Financial Statements [Line Items]  
Country of Incorporation United States – Delaware
Percentage Owned 73.00%
Farber Partners, LLC [Member]  
Schedule of Consolidated Financial Statements [Line Items]  
Country of Incorporation United States – Delaware
Percentage Owned 93.00%
Pharma Holdings, LLC [Member]  
Schedule of Consolidated Financial Statements [Line Items]  
Country of Incorporation United States – Delaware
Percentage Owned 90.00% [2]
LipoMedix Pharmaceuticals Ltd. [Member]  
Schedule of Consolidated Financial Statements [Line Items]  
Country of Incorporation Israel
Percentage Owned 95.00%
Altira Capital & Consulting, LLC [Member]  
Schedule of Consolidated Financial Statements [Line Items]  
Country of Incorporation United States – Delaware
Percentage Owned 67.00%
CS Pharma Holdings, LLC [Member]  
Schedule of Consolidated Financial Statements [Line Items]  
Country of Incorporation United States – Delaware
Percentage Owned 45.00% [2]
Day Three Labs, Inc.[Member]  
Schedule of Consolidated Financial Statements [Line Items]  
Country of Incorporation United States – Delaware
Percentage Owned 84.00%
Cornerstone Pharmaceuticals, Inc.[Member]  
Schedule of Consolidated Financial Statements [Line Items]  
Country of Incorporation United States – Delaware
Percentage Owned 67.00%
RP Finance, LLC [Member]  
Schedule of Consolidated Financial Statements [Line Items]  
Country of Incorporation United States – Delaware
Percentage Owned 38.00%
Cyclo Therapeutics, LLC [Member]  
Schedule of Consolidated Financial Statements [Line Items]  
Country of Incorporation United States – Nevada
Percentage Owned 100.00%
[1] In November 2022, the Company resolved to curtail its early-stage development efforts, including pre-clinical research at Barer. The decision was taken to reduce spending as the Company focuses on exploring strategic opportunities.
[2] 50% of CS Pharma Holdings, LLC is owned by Pharma Holdings, LLC. We have a 90% ownership interest in Pharma Holdings, LLC and, therefore, an effective 45% economic interest in CS Pharma Holdings, LLC. The Company, along with CS Pharma Holdings, LLC and Pharma Holdings LLC, collectively own securities representing 67% of the outstanding capital stock of Cornerstone.